United States · Funded startup

Who invested in Versiti

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$3.0Mraised across 1 round since 2026, from 1 source

Latest round
Grant, $3.0MFeb 2026
Investors
1
See who backed them

The rounds

  1. Feb 2026
    Grant$3.0M

    Source recorded

Founders and team

From Versiti's own website: 11 on the team.

  • Christine SadowskiChief of Staff & Vice President of Advancement
  • Chris MiskelPresident & CEO
  • Jessica DrouillardVP & Chief Quality Officer
  • Lynne BriggsVP & Chief Information Officer
  • Bart ReuterEVP & Chief Legal and Compliance Officer
  • Brad PietzEVP & Chief Laboratory Officer
  • Brian BautistaEVP & Chief Operating Officer
  • Derek TyusEVP & Chief Financial Officer
  • Gretchen JamesonEVP & Chief Marketing Officer
  • Jim WeidnerEVP & Chief Human Resources Officer
  • Colleen McCarthyVP of Versiti Organ and Tissue

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Versiti

Who invested in Versiti?

Versiti's investors include National Institutes of Health.

How much has Versiti raised?

Versiti has raised $3.0M across 1 round since 2026.

When did Versiti last raise?

Versiti's most recent round was a Grant of $3.0M in Feb 2026.

What was Versiti's biggest round?

Its most recent round, $3.0M in Feb 2026, is also its largest on record.

Who backed Versiti first?

Versiti's first round on record, in Feb 2026, was backed by National Institutes of Health.

What stage is Versiti at?

Versiti's latest named round is a Grant, in Feb 2026.

Where is Versiti based?

Versiti is based in the United States.

Companies like Versiti

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.